The pretrial order sets the stage for a September 8, 2026 trial. Lilly's stronger MIL win count (5 vs 3) and exclusion of Nektar's Teams chat evidence gives Lilly a procedural advantage. Monitor for any settlement announcements before trial; if none, the trial itself will be the key catalyst. The stock may see increased volatility as the trial date approaches.
Price Chart
Executive Summary
The court issued a pretrial order setting a jury trial for September 8, 2026, in Nektar Therapeutics' patent case against Eli Lilly. The order resolved motions in limine, with Nektar winning 3 of 7 and Lilly winning 5 of 7 (plus one deferred), giving Lilly a procedural edge. No damages, injunction, or liability ruling was made—this is a scheduling and evidence-ruling document, not a final outcome.
Court Ruling Details
Key Facts
- Jury trial set for September 8, 2026, in Nektar v. Eli Lilly patent case.
- Motions in limine resolved: Nektar won 3 of 7, Lilly won 5 of 7 (one deferred).
- Lilly's MIL No. 3 granted: Nektar may not use Lilly's Microsoft Teams chats from July 2023 to February 2025.
- No damages, injunction, or liability ruling in this pretrial order.
- Each side gets 13 hours for witness examinations and 3 peremptory challenges.
Financial Impact
No financial figures stated in the document.
Risk Factors
- Nektar lost 5 of 7 motions in limine, limiting its evidence at trial.
- Exclusion of Lilly's internal communications (Teams chats) could weaken Nektar's case.
- No settlement reached before trial—outcome binary and uncertain.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-6cec4005c8-NKTR |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 9w ago | Press Release | $73.02 $68.50 | ▼ −6.19% | ▼ −4.20% | $35.78 (−51.00%) |
Aug 9, 2026 10w ago | Institutional Cluster | $74.86 $75.44 | ▲ +0.77% | ▲ +1.69% | $35.78 (−52.20%) |
Aug 7, 2026 10w ago | Court Ruling | $76.48 $74.19 | ▼ −2.99% | ▼ −2.60% | $35.78 (−53.22%) |
Jul 28, 2026 11w ago | Press Release | $70.68 $73.77 | ▲ +4.37% | ▼ −0.65% | $35.78 (−49.38%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
May 21, 2026 21w ago | Insider Cluster | $66.61 $65.25 | ▲ +2.04% | ▲ +0.63% | $35.78 (+46.28%) |
May 8, 2026 23w ago | 8-K | $78.72 $56.23 | ▲ +28.57% | ▲ +28.27% | $35.78 (+54.55%) |
May 7, 2026 23w ago | 8-K | $81.89 $57.32 | ▼ −30.00% | ▼ −30.03% | $35.78 (−56.31%) |
Apr 24, 2026 25w ago | DEFA14A | $86.74 $65.56 | ▼ −24.42% | ▼ −29.37% | $35.78 (−58.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access